Related references
Note: Only part of the references are listed.Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: A systematic review
Noemie Kraaijpoel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
Michael Kreuter et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Juergen Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial
Francis Couturaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Venous thromboembolism in people with idiopathic pulmonary fibrosis: a population-based study
William Dalleywater et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study
Vidya Navaratnam et al.
THORAX (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
D. B. Sprunger et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis
Malgorzata Wygrecka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials
Florent Boutitie et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Venous Thromboembolism and Risk of Idiopathic Interstitial Pneumonia A Nationwide Study
Birgitte F. Sode et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism
Marc Carrier et al.
ANNALS OF INTERNAL MEDICINE (2010)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
S. Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease A Population-based Study
Richard B. Hubbard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
R. C. Chambers
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Acute Pulmonary Embolism
Stavros Konstantinides
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni et al.
HAEMATOLOGICA (2007)
Anticoagulant therapy for idiopathic pulmonary fibrosis
H Kubo et al.
CHEST (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
C Kearon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin - A randomized, controlled trial
RJ Beyth et al.
ANNALS OF INTERNAL MEDICINE (2000)
Recurrent venous thromboembolism after deep vein thrombosis -: Incidence and risk factors
PO Hansson et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Predictors of recurrence after deep vein thrombosis and pulmonary embolism -: A population-based cohort study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
